These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 28258374

  • 1. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.
    Lampalo M, Jukic I, Bingulac-Popovic J, Marunica I, Petlevski R, Pavlisa G, Popovic-Grle S.
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374
    [Abstract] [Full Text] [Related]

  • 2. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis.
    Ozbek OY, Ataç FB, Ogus E, Ozbek N.
    Allergy Asthma Proc; 2009 Jun; 30(1):41-6. PubMed ID: 19063817
    [Abstract] [Full Text] [Related]

  • 3. Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population.
    Bucková D, Izakovicová Hollá L, Vácha J.
    Allergy; 2002 May; 57(5):446-8. PubMed ID: 11972486
    [Abstract] [Full Text] [Related]

  • 4. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
    Pampuch A, Kowal K, Bodzenta-Lukaszyk A, Di Castelnuovo A, Chyczewski L, Donati MB, Iacoviello L.
    Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
    Ma Z, Paek D, Oh CK.
    Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
    [Abstract] [Full Text] [Related]

  • 6. The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype.
    Lampalo M, Jukić I, Bingulac-Popović J, Safić H, Ferara N, Popović-Grle S.
    Acta Clin Croat; 2018 Mar; 57(1):96-102. PubMed ID: 30256016
    [Abstract] [Full Text] [Related]

  • 7. Analysis of -675 4 g/5 G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients.
    Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, Donati MB, Iacoviello L.
    J Investig Allergol Clin Immunol; 2008 Mar; 18(4):284-92. PubMed ID: 18714537
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M.
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [Abstract] [Full Text] [Related]

  • 9. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
    Gürkan A, Emingil G, Saygan BH, Cinarcik S, Atilla G, Köse T, Berdeli A.
    J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
    [Abstract] [Full Text] [Related]

  • 10. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.
    Ann Hepatol; 2011 Dec; 10(4):493-501. PubMed ID: 21911891
    [Abstract] [Full Text] [Related]

  • 12. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 13. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 14. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Sep; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.
    Cosan D, Kurt E, Kurt H, Degirmenci I, Kuçukarabaci B, Metintas M, Kucuk MU, Gunes HV, Colak E.
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):543-6. PubMed ID: 19604112
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
    Hizawa N, Maeda Y, Konno S, Fukui Y, Takahashi D, Nishimura M.
    Clin Exp Allergy; 2006 Jul 01; 36(7):872-6. PubMed ID: 16839401
    [Abstract] [Full Text] [Related]

  • 19. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug 01; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 20. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan 01; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.